Core Insights - Trupanion, Inc. will host its Annual Investor Day on September 17, 2025, aimed at providing shareholders with insights into the company's achievements and strategic vision [1][2] - The event will include presentations and a Q&A session with teams responsible for executing the company's strategic growth plan [2] Company Overview - Trupanion is a leader in medical insurance for pets, specifically cats and dogs, with over 1,000,000 pets currently enrolled across the United States, Canada, and parts of Continental Europe [3] - The company has been operational for over two decades, focusing on providing pet owners with peace of mind through unlimited payouts for the life of their pets [3] - Trupanion is unique in North America for its patented technology that allows for direct payment to veterinarians at the time of checkout [3] - The company is publicly traded on NASDAQ under the symbol "TRUP" and was founded in 2000, with its headquarters located in Seattle, WA [3]

May 2025 Trupanion Investor Presentation This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 relating to, among other things, expectations, plans, prospects and financial results for Trupanion, including, but not limited to, its expectations regarding its ability to execute its business plans. These forward-looking statements are based upon the current expectations and beliefs of Trupanio ...

Core Points - Trupanion held its annual awards event on June 18, 2025, to honor the veterinary community for their significant contributions to pet health and well-being [1][3] - The awards program received over 47,000 public votes, highlighting the importance of veterinary teams in North America [2][3] - Trupanion established June 18 as Veterinary Appreciation Day in 2015 to recognize the efforts of veterinary professionals [3] Award Winners - The 2025 Veterinary Appreciation Day Awards recognized 12 winners across various categories, including Veterinarian of the Year and Veterinary Professional of the Year [4][5] - Winners included Yafen Zhen, DVM from VCA San Martin Animal Hospital, and Marie Marquez, CSR from VCA Veterinary Care Animal Hospital, among others [6][8][9] - The awards spanned multiple regions in the U.S. and Canada, showcasing the diverse talent within the veterinary field [5][7] Company Overview - Trupanion is a leading provider of medical insurance for pets in North America, with over 1,000,000 pets enrolled [11] - The company offers unlimited payouts for the life of pets and has a patented process for direct payment to veterinarians at checkout [11] - Trupanion is publicly traded on NASDAQ under the symbol "TRUP" and was founded in 2000, headquartered in Seattle, WA [11]

Core Viewpoint - Trupanion (TRUP) has received a Zacks Rank 2 (Buy) upgrade, indicating a positive outlook driven by rising earnings estimates, which significantly influence stock prices [1][2][4]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of changing earnings estimates in determining stock price movements, making it a valuable tool for investors [2][3]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in stock price movements [3]. Trupanion's Earnings Outlook - For the fiscal year ending December 2025, Trupanion is projected to earn $0.07 per share, reflecting a 130.4% increase from the previous year [7]. - Over the past three months, the Zacks Consensus Estimate for Trupanion has risen by 16.7%, indicating a positive trend in earnings expectations [7]. Zacks Rank System - The Zacks Rank system classifies stocks based on earnings estimates into five groups, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [6]. - Trupanion's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [9].

Trupanion (TRUP) FY Conference Summary Company Overview - **Company**: Trupanion - **Industry**: Pet Insurance - **Founded**: 25 years ago in Canada, now based in Seattle - **Coverage**: Over 1 million pets in North America, recently expanded into Europe [3][4] Core Industry Insights - **Market Penetration**: Less than 4% of pets in North America have pet insurance, indicating a significant growth opportunity [4][22] - **Market Size**: Approximately 180 million cats and dogs in North America, with around 20 million veterinary visits annually [23] - **New Pet Leads**: 14 million new puppies and kittens born each year in North America, translating to about 1.1 million new pet leads monthly [23] Business Model and Financials - **Revenue Model**: Monthly subscription revenue model with a cost-plus approach [5][37] - **Retention Rates**: Industry-leading retention rates due to comprehensive coverage and lifetime pricing strategies [6][11] - **Profitability**: Adjusted operating income is reinvested to grow the business, with a focus on maintaining a 15% operating margin [39][37] Product Offering - **Coverage Features**: - Comprehensive lifelong coverage with a lifetime deductible per condition [10][12] - No payout limits, allowing pet parents to opt for the best treatment without financial constraints [16] - Direct payment to veterinarians at checkout, reducing upfront costs for pet owners [18] - **Value Proposition**: Designed to provide 71 cents on the dollar value for pet parents, with 1,200,000 pricing categories tailored to various demographics [13][14] Competitive Advantages - **Veterinary Relationships**: Strong partnerships with 28,000 veterinary hospitals, fostering trust and credibility [20][61] - **Direct Recommendations**: High endorsement from veterinarians, who often choose Trupanion for their own pets [62] - **Data-Driven Insights**: Real-time data collection allows for effective pricing and product adjustments [21] Market Dynamics - **COVID-19 Impact**: Initial surge in pet ownership during the pandemic led to increased leads, but the market has since normalized [54] - **Inflationary Pressures**: Significant inflation in veterinary costs (up to 15% in recent years) has impacted margins, but pricing adjustments are being made to recover [36][55] Growth Strategy - **Lead Generation**: Focus on increasing leads from veterinary partners and improving conversion rates [44][65] - **Product Diversification**: Exploring additional product lines, such as pet food, to enhance margins and retention [46][48] - **International Expansion**: Entering European markets with a focus on providing similar coverage standards as in North America [26][27] Future Outlook - **Market Potential**: Each percentage point of market penetration in North America is estimated to be worth $1.3 billion [49] - **Investment Discipline**: Emphasis on judicious growth with a focus on internal rate of return between 30% to 40% [66][67] Conclusion - **Overall Position**: Trupanion is well-positioned in a growing and underpenetrated market, with a strong value proposition and competitive advantages that support long-term growth and sustainability [49]

Company Overview - Trupanion, Inc. is a leader in medical insurance for pets, specifically cats and dogs, operating in the United States, Canada, and parts of Continental Europe with over 1,000,000 pets currently enrolled [2] - The company has been providing pet owners with peace of mind for over two decades, focusing on pet recovery rather than financial stress [2] - Trupanion offers unlimited payouts for the life of pets and is the only North American provider with technology to pay veterinarians directly at the time of checkout [2] Upcoming Events - Margi Tooth, the CEO and President of Trupanion, will present at the William Blair 45th Annual Growth Stock Conference on June 3, 2025, at 3:20 p.m. CT [1] - The presentation will be available via a live webcast on Trupanion's Investor Relations website [1]

Quarterly Earnings Supplement Q1 2025 Total Subscription Revenue Growth $3.1 $4.4 $5.3 $6.3 $7.6 $8.8 $9.9 $10.7 $12.0 $13.2 $14.5 $15.7 $17.0 $18.4 $20.0 $21.4 $22.9 $24.9 $27.1 $28.6 $30.1 $32.2 $34.4 $36.7 $39.1 $42.2 $44.6 $47.4 $50.2 $52.6 $56.5 $59.0 $61.5 $63.9 $67.4 $70.9 $74.2 $77.7 $82.6 $86.6 $89.5 $92.5 $99.4 $106.4 $113.3 $120.4 $127.1 $134.1 $139.8 $145.8 $152.4 $158.6 $165.2 $173.3 $182.9 $191.5 $201.1 $208.6 $219.0 $227.8 $233.1 $0 $50.0 $100.0 $150.0 $200.0 $250.0 ($ in millions) Revenue fr ...

Core Insights - Trupanion is hosting a webinar on H5N1 bird flu, focusing on its impact on pets and the veterinary community [1][2] - The webinar aims to provide veterinary professionals and pet parents with the latest information and practical guidance on avian flu in pets [2][3] Company Overview - Trupanion is a leading provider of medical insurance for pets, with over 1,000,000 pets enrolled across the United States, Canada, Europe, and Australia [7] - The company offers unlimited payouts for the life of pets and has a patented process that allows for direct payment to veterinarians at checkout [7] Webinar Details - The webinar titled "Bird Flu: What We Know Now" will be available on-demand on May 8th, 2025, and is hosted by Dr. Steve Weinrauch, Chief Veterinary/Product Officer at Trupanion [2] - Panelists include experts from various veterinary and public health organizations, discussing topics such as at-risk pet populations, virus transmission, clinical signs in pets, and preventative measures [6] Health Monitoring System - Trupanion's Pet & Public Health Early Warning Detection System uses real-time health data from over 11,000 veterinary hospitals to identify illness trends affecting companion animals [4] - The system collaborates with health authorities to proactively detect and respond to potential health threats [4]

Group 1 - Trupanion (TRUP) closed at $36.44, with a 4.1% gain over the past four weeks, and a mean price target of $54.75 indicating a 50.3% upside potential [1] - The average price targets range from a low of $41 to a high of $65, with a standard deviation of $10.66, suggesting a variability in analyst estimates [2] - Analysts show strong agreement on Trupanion's ability to report better earnings, with a positive trend in earnings estimate revisions indicating potential upside [4][11] Group 2 - Over the last 30 days, the Zacks Consensus Estimate for Trupanion's current year earnings has increased by 64.3%, with two estimates moving higher and no negative revisions [12] - Trupanion holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [10][13]

Core Insights - Trupanion reported revenue of $341.98 million for the quarter ended March 2025, reflecting an 11.7% increase year-over-year and a surprise of +1.17% over the Zacks Consensus Estimate of $338.01 million [1] - The company's EPS was -$0.03, an improvement from -$0.16 in the same quarter last year, with a surprise of +25.00% compared to the consensus estimate of -$0.04 [1] Revenue Breakdown - Revenue from Other Business was $108.91 million, exceeding the three-analyst average estimate of $106.10 million, representing a year-over-year change of +3.7% [4] - Subscription Business revenue reached $233.06 million, slightly above the average estimate of $231.92 million, with a year-over-year increase of +15.9% [4] Operating Income - Other business adjusted operating income (non-GAAP) was reported at $1.17 million, surpassing the average estimate of $0.83 million from three analysts [4] - Subscription adjusted operating income (non-GAAP) was $30.02 million, exceeding the average estimate of $27.50 million from three analysts [4] Stock Performance - Trupanion's shares have returned -1.8% over the past month, compared to a -0.7% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]